In vivo respiratory disease models are valuable in the identification of potential medications targeted at treating human respiratory diseases. Common respiratory diseases include lung fibrosis or the emerging COVID-19, where highly efficacious treatments are limited and where in vivo disease models can help to screen for potential new treatments. In …
![In vivo respiratory models](https://ddblog.labcorp.com/wp-content/uploads/2020/08/103588_16129641_XXL1-450x300.jpg)